PSMF Convenes the International Patient Safety Community for its 2017 Midyear Planning Meeting at Inova Center for Personalized Health
14.7.2017 06:17 | Business Wire
The Patient Safety Movement Foundation (PSMF) brought together over 100 medical care providers, hospital administrators, and patient safety experts and advocates to discuss ongoing challenges and refine patient safety solutions at its fifth annual Midyear Planning Meeting. The day-long, invitation-only “working meeting” was co-convened with Inova Heart & Vascular Institute at the Inova Center for Personalized Health in Falls Church, Virginia.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170713006312/en/
Jade Perdue, Senior Policy Analyst at the Centers for Medicare & Medicaid Services, presented the meeting’s keynote, explaining the importance of Patient and Family Engagement and the role it plays throughout the Partnerships for Patients (PFP) campaign. To date, PFP has engaged thousands of hospitals in all 50 states and Puerto Rico. Other speakers addressed the need for increased transparency, communication and optimal resolution (CANDOR), the importance of “Influence” and the importance of data and commitment validation.
The meeting also provided an opportunity for open discussion to review and identify any needed revisions or additions to the existing Actionable Patient Safety Solutions (APSS) in six breakout sessions, which covered obstetric safety, airway safety, creating a culture of safety, medication errors, venous thromboembolisms, and early detection and treatment of sepsis. The sessions’ goals were to ensure that each APSS represents evidence-based best practices to overcome the leading problems hospitals are facing today.
“As 2020 draws near, it is essential that we continue to take action, accelerate our pace and make the fundamental changes needed to ensure we reach our goal of zero by 2020,” said Joe Kiani, Founder of the Patient Safety Movement Foundation. “If the hard work, passion and dedication shown by those that attended this year’s Midyear Planning Meeting is an indication, we will achieve our goal. The key is mutual learning, shared responsibility and mindfulness when we are dealing with patients and their families. As always, I couldn’t be more grateful for our partnership with Inova Heart & Vascular Institute and Dr. Charles Murphy.”
"Zero Preventable Deaths by 2020: Inova Heart and Vascular Institute is proud to partner with the Patient Safety Movement Foundation in reaching this goal,” said Dr. Charles E. Murphy, Chief Patient Safety Officer for Inova Heart & Vascular Institute. “Today's meeting highlighted the strength behind the movement as we continue to push forward in promoting this mutual and essential objective for the advancement of healthcare worldwide."
Inova is a not-for-profit healthcare system based in Northern Virginia that serves more than 2 million people each year from throughout the Washington, DC, metro area and beyond. Inova is a comprehensive network of hospitals, outpatient services and facilities, primary and specialty care practices, and health and wellness initiatives. It is recognized as a global leader in developing and applying personalized health; connecting researchers, clinicians, and patients; and integrating genomic research for patient care, prevention, and wellness.
About the Patient Safety Movement Foundation
More than 200,000 people die every year in U.S. hospitals and 3 million worldwide in ways that could have been prevented. The Patient Safety Movement Foundation was established through the support of the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare to reduce that number of preventable deaths to 0 by 2020 (0X2020). Improving patient safety will require a collaborative effort from all stakeholders, including patients, healthcare providers, medical technology companies, government, employers, and private payers. The Patient Safety Movement Foundation works with all stakeholders to address the problems with actionable solutions for patient safety. The Foundation also convenes the World Patient Safety, Science and Technology Summit. The Summit brings together some of the world’s best minds for thought-provoking discussions and new ideas to challenge the status quo. By presenting specific, high-impact solutions to meet patient safety challenges, called Actionable Patient Safety Solutions, encouraging medical technology companies to share the data their products are purchased for, and asking hospitals to make commitments to implement Actionable Patient Safety Solutions, the Patient Safety Movement Foundation is working toward zero preventable deaths by 2020. Visit http://patientsafetymovement.org/.
@0X2020 #patientsafety #0X2020
Patient Safety Movement Foundation
Irene Paigah, 858-859-7001
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Major Terrorist Plot Foiled in Saudi Arabia, Ministry of Interior Announces21.7.2017 18:33 | Pressemelding
The following is a statement from Saudi Arabia’s Ministry of Culture and Information: This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005575/en/ Weapons and other items found in the possession of the three terrorists are an indication of the ugliness and severity of the acts of terrorism they were planning to carry out, victimizing innocent lives and private and public property. (Photo: ME NewsWire) The Saudi Ministry of Interior has announced that a major terrorist attack was prevented by security services in the city of Saihat in the Qatif governorate. On the evening of Friday, July 14th, security services intercepted a stolen Toyota Corolla vehicle in a busy, built-up district of the city. As the stolen vehicle was surrounded by security services, three men in the ca
Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV21.7.2017 12:09 | Pressemelding
Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for SYMTUZA™ (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single tablet regimen (STR). If approved, it will be the only darunavir-based STR indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with body weight of at least 40 kg, with genotypic testing guiding use. This STR combines the proven efficacy and durability of darunavir with the improved renal laboratory and bone mineral density profile of F/TAF as compared to F/TDF (tenofovir disoproxil fumarate), and will be the only treatment that could deliver the adherence advantag
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (Telotristat Ethyl), for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy21.7.2017 11:26 | Pressemelding
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion recommending the approval of Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. The CHMP positive opinion will now be reviewed by the European Commission (EC), which has the authority to approve medicines for use in the 28 countries of the European Union, as well as Norway, Liechtenstein and Iceland. David Meek, Chief Executive Officer of Ipsen, said: “The positive CHMP opinion for Xermelo ® is an important milestone towards providing innovative s
Schlumberger Announces Second-Quarter 2017 Results21.7.2017 11:00 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the second quarter of 2017. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2017 Mar. 31, 2017 Jun. 30, 2016
NRI Secure Launches Japan's First "Blockchain Assessment" Service21.7.2017 07:00 | Pressemelding
NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/ Overview of the "Blockchain Assessment" Service (Graphic: Business Wire) As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or eve
Business Figures for the First Half of 2017: Sartorius Continues to Grow21.7.2017 05:00 | Pressemelding
Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, continues on the growth track. In the first half of 2017, solid organic business development and two acquisitions led to a significant increase in sales revenue and earnings1. "Sartorius has continued its dynamic, profitable development," said CEO and Executive Board Chairman Dr. Joachim Kreuzburg in commenting on the company's first-half performance. "Both divisions achieved solid organic growth in an environment that was especially challenging in North America, and have made quick progress in integrating the businesses most recently acquired. In the Lab Products & Services Division, the bioanalytics unit newly created by our acquisitions has already contributed significant revenues and earnings. We see further considerable growth potential ahead for this business just as for the
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom